Corrigendum to “Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq”
Table 1
Patient and disease characteristics of the current study.
Parameter
Frequency
Number of evaluated patients
Percent
Demographic data
Age (years)
<18
90
159
56.6
18-35
55
159
34.6
>35
14
159
8.8
Gender
Male
90
159
56.6
Female
69
159
43.4
Splenectomized
52
159
32.75
Serum ferritin (μg/L)
<1000
122
159
76.7
>1000
37
159
23.3
Treatment
None transfused
33
159
20.7
Occasional transfusion
75
159
47.2
Regular transfusion
51
159
32.1
Iron chelation
63
159
39.6
Hydroxyurea
75
159
47.2
Complications
Facial deformity
99
159
62.3
Osteoporosis
17
60
28.3
Growth retardation
25
90
27.8
Subclinical hypothyroidism
22
131
16.8
Cholelithiasis
19
137
13.8
Pulmonary hypertension
18
159
11.3
Abnormal liver function
12
159
7.5
Thrombosis
2
159
1.3
EMH
1
159
0.6
Leg ulcer
1
159
0.6
Osteoporosis and subclinical hypothyroidism were evaluated in years old and/or symptomatic, growth retardation ( below 3rd percentile for the mean age and gender) in years, and cholelithiasis estimated in 137 patient excluding the 22 patients that underwent cholecystectomy.
